title: [Disease-free survival of acute leukemia patients receiving autologous bone marrow transplant following intensive chemotherapy--a report of 11 cases].
abstract: Eleven cases of acute leukemia patients were treated with autologous bone marrow transplantation (ABMT) following intensive chemotherapy with TACC protocol. Among them, eight were in first remission, three in second remission. The median age was 38 years (24-45 years). Bone marrow was purged in vitro before transplantation with procaine and hyperthermia in three cases with acute promyelocytic leukemia. In all patients, ABMT was successful. The results of treatment are as follows: as of May, 1994, the median remission and disease-free survival period was 31 months (6-57), seven cases have been in complete remission for 6-57 months (median 42 months) after treatment and are still alive. In four cases, ABMT was complicated by infection but it was controlled by antibiotics.
authors.affiliation: Jiangsu Institute of Hematology, Suzhou.
authors.forename: X
authors.initials: X
authors.lastname: Xia
authors.forename: B
authors.initials: B
authors.lastname: Lin
authors.forename: D
authors.initials: D
authors.lastname: Wu
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016465:Bone Marrow Purging; D016026:Bone Marrow Transplantation; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000628:therapy*; D008130:Lomustine / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D013866:Thioguanine / Q000008:administration & dosage
chemical_list: D003561:Cytarabine; D008130:Lomustine; D003520:Cyclophosphamide; D013866:Thioguanine